A pilot phase 1 study of SequestOx (Immediate release Oxycodone Hydrochloride) compared to the reference drug, Roxicodone, to treat healthy male and female volunteers moderate to severe acute pain in the fed state

Trial Profile

A pilot phase 1 study of SequestOx (Immediate release Oxycodone Hydrochloride) compared to the reference drug, Roxicodone, to treat healthy male and female volunteers moderate to severe acute pain in the fed state

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2018

At a glance

  • Drugs Oxycodone/naltrexone (Primary) ; Oxycodone
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Feb 2018 New trial record
    • 30 Jan 2018 According to a Elite Pharmaceuticals media release, company is reviewing with FDA these results of the study for re-submission of the NDA.
    • 30 Jan 2018 Results published in the Elite Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top